Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium.
J Neurol Sci. 2019 Jul 15;402:121-130. doi: 10.1016/j.jns.2019.05.016. Epub 2019 May 15.
J Neurol Sci. 2019.
PMID: 31129265
Review.